David Windley
Stock Analyst at Jefferies
(3.53)
# 850
Out of 5,148 analysts
204
Total ratings
65.55%
Success rate
13%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Upgrades: Buy | $175 → $135 | $108.27 | +24.69% | 16 | Feb 23, 2026 | |
| MEDP Medpace Holdings | Upgrades: Buy | $560 | $457.47 | +22.41% | 7 | Feb 13, 2026 | |
| HUM Humana | Maintains: Buy | $310 → $235 | $187.28 | +25.48% | 20 | Feb 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $255 | $174.27 | +46.32% | 6 | Feb 6, 2026 | |
| UNH UnitedHealth Group | Maintains: Buy | $418 → $340 | $294.93 | +15.28% | 28 | Jan 28, 2026 | |
| DEO Diageo | Downgrades: Neutral | n/a | $86.53 | - | 1 | Dec 3, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $10.56 | -10.04% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $178.61 | +9.18% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $247.77 | +6.15% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $0.86 | +218.77% | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $64 → $61 | $44.60 | +36.77% | 28 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $12 | $13.98 | -14.16% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $290.85 | +45.09% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $152.42 | +94.86% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.31 | +1,125.49% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $294.07 | +105.39% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $496.25 | -24.43% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $15.91 | -2.58% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $181.45 | +48.80% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $7.05 | +119.86% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $251.25 | +113.33% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $15.09 | +92.18% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $5.16 | +4,706.20% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $0.85 | - | 5 | Oct 9, 2017 |
ICON Public Limited Company
Feb 23, 2026
Upgrades: Buy
Price Target: $175 → $135
Current: $108.27
Upside: +24.69%
Medpace Holdings
Feb 13, 2026
Upgrades: Buy
Price Target: $560
Current: $457.47
Upside: +22.41%
Humana
Feb 12, 2026
Maintains: Buy
Price Target: $310 → $235
Current: $187.28
Upside: +25.48%
IQVIA Holdings
Feb 6, 2026
Maintains: Buy
Price Target: $270 → $255
Current: $174.27
Upside: +46.32%
UnitedHealth Group
Jan 28, 2026
Maintains: Buy
Price Target: $418 → $340
Current: $294.93
Upside: +15.28%
Diageo
Dec 3, 2025
Downgrades: Neutral
Price Target: n/a
Current: $86.53
Upside: -
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $10.56
Upside: -10.04%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $178.61
Upside: +9.18%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $247.77
Upside: +6.15%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $0.86
Upside: +218.77%
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $44.60
Upside: +36.77%
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $13.98
Upside: -14.16%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $290.85
Upside: +45.09%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $152.42
Upside: +94.86%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.31
Upside: +1,125.49%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $294.07
Upside: +105.39%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $496.25
Upside: -24.43%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $15.91
Upside: -2.58%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $181.45
Upside: +48.80%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $7.05
Upside: +119.86%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $251.25
Upside: +113.33%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $15.09
Upside: +92.18%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $5.16
Upside: +4,706.20%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $0.85
Upside: -